Francois Rochon - Giverny Capital Inc.
Holding/activity history for Edwards Lifesciences Corp. (EW)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2024 Q4 | 257 | <0.01 | Reduce 99.94% | 1.12 | $74.03 | $19,026 | SEC |
| 2024 Q3 | 446,288 | 1.12 | Add 0.06% | <0.01 | $65.99 | $29,450,545 | SEC |
| 2024 Q2 | 446,016 | 1.74 | Add 0.07% | <0.01 | $92.37 | $41,198,498 | SEC |
| 2024 Q1 | 445,718 | 1.73 | Add 1.09% | 0.02 | $95.56 | $42,592,812 | SEC |
| 2023 Q4 | 440,906 | 1.58 | Add 0.07% | <0.01 | $76.25 | $33,619,083 | SEC |
| 2023 Q3 | 440,602 | 1.66 | Add 0.16% | <0.01 | $69.28 | $30,524,907 | SEC |
| 2023 Q2 | 439,896 | 2.18 | Add 6.01% | 0.12 | $94.33 | $41,495,390 | SEC |
| 2023 Q1 | 414,975 | 2.07 | Reduce 2.63% | 0.05 | $82.73 | $34,330,882 | SEC |
| 2022 Q4 | 426,173 | 1.97 | Reduce 0.94% | 0.02 | $74.61 | $31,796,768 | SEC |
| 2022 Q3 | 430,196 | 2.41 | Add 3.19% | 0.07 | $82.63 | $35,547,000 | SEC |
| 2022 Q2 | 416,882 | 2.61 | Add 2.91% | 0.07 | $95.09 | $39,641,000 | SEC |
| 2022 Q1 | 405,091 | 2.69 | Reduce 0.17% | <0.01 | $117.72 | $47,687,000 | SEC |
| 2021 Q4 | 405,762 | 2.80 | Add 0.90% | 0.02 | $129.55 | $52,566,000 | SEC |
| 2021 Q3 | 402,150 | 2.71 | Reduce 0.83% | 0.02 | $113.21 | $45,527,000 | SEC |
| 2021 Q2 | 405,529 | 2.55 | Add 3.94% | 0.10 | $103.57 | $42,001,000 | SEC |
| 2021 Q1 | 390,140 | 2.18 | Add 0.60% | 0.01 | $83.64 | $32,631,000 | SEC |
| 2020 Q4 | 387,814 | 2.71 | Add 3.85% | 0.10 | $0.09 | $35,380 | SEC |
| 2020 Q3 | 373,422 | 2.73 | Add 0.21% | <0.01 | $79.82 | $29,807,000 | SEC |
| 2020 Q2 | 372,627 | 2.56 | Add 214.65% | 1.75 | $69.11 | $25,752,000 | SEC |
| 2020 Q1 | 118,426 | 2.84 | Reduce 7.85% | 0.21 | $188.62 | $22,338,000 | SEC |
| 2019 Q4 | 128,515 | 2.71 | Add 1.01% | 0.03 | $233.29 | $29,981,000 | SEC |
| 2019 Q3 | 127,233 | 2.79 | Add 0.19% | <0.01 | $219.91 | $27,980,000 | SEC |
| 2019 Q2 | 126,990 | 2.37 | Add 2.47% | 0.06 | $184.74 | $23,460,000 | SEC |
| 2019 Q1 | 123,923 | 2.72 | Add 1.43% | 0.04 | $191.33 | $23,710,000 | SEC |
| 2018 Q4 | 122,178 | 2.47 | Reduce 32.38% | 1.22 | $153.17 | $18,714,000 | SEC |
| 2018 Q3 | 180,690 | 3.78 | Add 4.74% | 0.17 | $174.10 | $31,458,000 | SEC |
| 2018 Q2 | 172,508 | 3.53 | Add 0.78% | 0.03 | $145.57 | $25,112,000 | SEC |
| 2018 Q1 | 171,166 | 3.48 | Add 5.94% | 0.20 | $139.52 | $23,881,000 | SEC |
| 2017 Q4 | 161,571 | 2.72 | Buy | 2.72 | $112.71 | $18,211,000 | SEC |